Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster presentation 1

712 - Salmonella inhibit tumor angiogenesis by downregulation of vascular endothelial growth factor via hypoxic-induced factor-1α


19 Dec 2015


Poster presentation 1


Che-Hsin Lee


Annals of Oncology (2015) 26 (suppl_9): 1-7. 10.1093/annonc/mdv517


C. Lee

Author affiliations

  • Department Of Microbiology, China Medical University, 40402 - Taichung/TW


Abstract 712


Successful cancer therapy relies on the development of anticancer agents that can selectively and effectively deliver to tumor sites. Salmonella are Gram-negative, facultative anaerobes that are a common cause of host intestinal infections. Salmonella grow under aerobic and anaerobic conditions and they have been proven the capable of inhibiting tumor growth. However, the molecular mechanism that by which Salmonella inhibit tumor growth is still unclear. Angiogenesis plays an important role in the development and progression of tumors. We investigated the antitumor effect of Salmonella in a syngeneic murine tumor model.


Hypoxia-inducible factor-1 (HIF-1) α plays a significant role in tumor angiogenesis. We examined the molecular mechanism by which Salmonella regulate HIF-1α-dependent expression of vascular endothelial growth factor (VEGF), which is an important angiogenic factor.


Herein, the expression of VEGF was decreased by treatment with Salmonella in tumor cells .The conditioned medium from Salmonella -treated cells inhibited the proliferation of endothelial cells. Salmonella inhibited the expression of HIF-1α, as well as downregulated its upstream signal mediator protein kinase B (AKT). Salmonella significantly inhibited the tumor growth in vivo and immunohistochemical studies in the tumors revealed decreased intratumoral microvessel density.


These results suggest that the Salmonella therapy, which exerts anti-angiogenic activities, represents a promising strategy for the treatment of tumors.

Clinical trial identification


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings